EU scheme commits $350 mln to research Ebola vaccines and tests
The Europe Union and drugmakers pledged on Thursday to invest 280 million euros ($350 million) into Ebola research, with the lion's share going to fast-track the testing and manufacture of potential vaccines.
The funding will go to projects backed by the Innovative Medicines Initiative (IMI), a public-private scheme jointly paid for by the European Commission and the pharmaceuticals industry.
